You are here: Industry Insights > Eli Lilly

News List

Eli Lilly plots 250 job cuts in €100M revamp of French plant fiercepharma
January 13, 2019
Boehringer Ingelheim and Sanofi aren't the only pharma companies chopping jobs in France. Now, Eli Lilly says it's cutting 250 positions as part of a "modernization" effort at a plant in Fegersheim.
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy firstwordpharma
January 13, 2019
Eli Lilly CEO Dave Ricks said that as the company looks for deals to enhance its pipeline of future treatments it will leave CAR-T therapies for cancer and gene therapy for rare diseases to others, as reported Yahoo Finance Friday.
Eli Lilly's new Trulicity TV ad counters Trump with first-ever pricing information fiercepharma
January 10, 2019
Eli Lilly is officially the first pharma to add pricing information to a TV commercial. The move—initially for Trulicity in a spot that debuted this week—will expand to its other TV-promoted drugs by the end of next month.
Eli Lilly to buy Loxo Oncology for $8 billion expressbpd
January 10, 2019
The deal follows Bristol-Myers Squibb Co agreement last week to buy Celgene Corp for $74 billion, and gives Lilly access to Loxo’s portfolio of targeted medicines that treat cancers caused by rare gene mutations
Drugmaker Won't Put Price in TV Ads, But Patients Can Look It Up firstwordpharma
January 09, 2019
Eli Lilly won't put the price of its prescription drugs in television ads, but as of Tuesday, the company will start airing ads touting a website that will have information about drug list prices, patient assistance programs and average patient cost for m
Eli Lilly grabs spotlight at J.P. Morgan with $8B Loxo Oncology buyout fiercepharma
January 08, 2019
On the first day of biopharma’s largest confab, the J.P. Morgan Healthcare Conference, Eli Lilly confirmed that big-ticket M&A is back in fashion in the industry.
Eli Lilly and Evidation expand digital biomarker collaboration to data from smartphones and wearables fiercebiotech
December 26, 2018
Eli Lilly & Co. is expanding its collaboration with Evidation Health into a multiyear project aimed at developing digital biomarkers for disease, derived from smartphones, wearable sensors and even voice data...
Eli Lilly files for FDA approval of migraine drug lasmiditan fiercebiotech
November 15, 2018
Eli Lilly has filed for FDA approval of migraine drug lasmiditan. The Big Pharma is seeking approval of the 5-HT1F agonist on the strength of late-phase data showing the drug clears headache pain in two hours in some patients.
OrbiMed, Vivo lead $80M B round for Terns Pharma fiercebiotech
November 02, 2018
Terns Pharmaceuticals has bagged $80 million to bankroll a pipeline of drugs for nonalcoholic steatohepatitis (NASH). The company, which has one foot in San Mateo, California...
EU nod for Lilly’s new breast cancer drug pharmatimes
October 11, 2018
Eli Lilly’s CDK 4 and 6 inhibitor Verzenios has been approved in Europe for the treatment of certain metastatic breast cancers.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page